Can a virtual support program ease the burden of chronic GVHD?

NCT ID NCT06910969

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a group-based telehealth program called HORIZONS for adults living with chronic graft-versus-host disease (cGVHD) after a stem cell transplant. The program includes 8 sessions led by a therapist to help with self-management and quality of life. Researchers will compare it to just receiving a booklet, aiming to see if the group program makes a real difference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
HORIZONS multidisciplinary group-based telehealth intervention
What this could lead to
If it works, this could provide a proven way to help people with chronic GVHD feel better and manage their condition more effectively.
What could go wrong
This is a behavioral intervention, not a drug, so it may not work for everyone. The trial is still recruiting, and results are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE MARROW TRANSPLANT COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

  • University of Miami Sylvester Comprehensive Cancer Center

    RECRUITING

    Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.